The health care paradigm shift is the basis for the life science cluster activities
Denmark plays an important part at the international life science scene, and it is of utmost importance to the Danish welfare structure that Denmark fosters academic and pharmaceutical research and development activities in the life science field on a continued and foresighted base.
The life science environment took a giant leap by the decoding of the human genome about 15 years ago. Today we more deeply understand the fundamental molecular principles of disease, and this knowledge transforms the development of medicine, and consequently the health care system.
In the future doctors will apply new diagnostic methods to choose the right medication and treatment. Biomarkers will provide increasingly detailed information as to which therapy, under what circumstances, at what point in time and in what dosage achieves a positive outcome.
The four P’s
These expanding treatment opportunities is a key driver of the total paradigm shift in public health care, where the so-called “Four Ps” form the basic building blocks of future medicine, treatment principles and preventive actions: anticipating (Predictive) and preventing (Pre-emptive) disease in the future will involve highly precise, personalized diagnosis and corresponding treatment (Personalized). Furthermore, patients will gradually play a more active decision-making role in their own health care (Participatory).
Read article by Per Spindler, Biopeople here.
4 January 2023
EDAH - a new European project ahead